Posts filed under: Peripheral Vascular

Register to receive a free U.S. Market Report Suite for Peripheral Vascular Devices and Accessories – MedSuite report synopsis and brochure Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, has announced 510(k) clearance by the Food...
Continue Reading →
Pantheris Image-Guided Atherectomy Device Designed to Empower Physicians to Precisely Treat Peripheral Artery Disease...
Continue Reading →
The PMA covers the treatment of atherosclerotic lesions in common and external iliac arteries with diameters of 4.5mm to 12.0mm and lesion lengths of up to 100mm, Murray Hill, N.J.-based Bard said....
Continue Reading →
Contego Medical, LLC recently announced that it has received CE Marking of its Vanguard IEP™ Peripheral Balloon Angioplasty System with Integrated Embolic Protection. ...
Continue Reading →
FDA approval of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis marks the availability of the only balloon expandable stent graft with an indication for the iliac artery. ...
Continue Reading →
Register to receive a free US Peripheral Vascular Device Market – 2016 report synopsis and brochure W.L. Gore recently announced the U.S. Food and Drug Administration (FDA) approval of the GORE® TIGRIS® Vascular Stent, a dual-component stent with a fluoropolymer...
Continue Reading →
The European peripheral vascular device market value is expected to reach over €1.4 billion by 2022. The strong growth in this market is a result of the increase in usage of radiolabeled and drug-eluting beads....
Continue Reading →
The U.S. power-injectable implantable port market is expected to increase over the forecast period, driven predominantly by cancer treatments that require long-term vascular access....
Continue Reading →
Growth in the value of the covered stent segment in the U.S. peripheral vascular stent market will outpace growth in the value of the bare-metal stent segment over the forecast period....
Continue Reading →
Teleflex recently announced that the FDA has labeled the global recall of more than 47,000 Arrow International intra-aortic balloon catheter kits and percutaneous insertion kits as a Class I corrective action....
Continue Reading →

Thank you!

CLOSE

Login

Sign Up


Already have an account? Sign in

×